Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies.
Hillen H, Barghorn S, Striebinger A, Labkovsky B, Müller R, Nimmrich V, Nolte MW, Perez-Cruz C, van der Auwera I, van Leuven F, van Gaalen M, Bespalov AY, Schoemaker H, Sullivan JP, Ebert U.
Hillen H, et al. Among authors: schoemaker h.
J Neurosci. 2010 Aug 4;30(31):10369-79. doi: 10.1523/JNEUROSCI.5721-09.2010.
J Neurosci. 2010.
PMID: 20685980
Free PMC article.